{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:08:58Z","timestamp":1790489338100,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type 2 diabetes is characterized by insulin tolerance in target cells followed by a reduction of pancreatic \u03b2-cell mass. Islet amyloid polypeptide oligomeric assemblies were shown to contribute to \u03b2-cell apoptosis by forming discrete pores that destabilize the cellular membrane. We previously characterized \u03b1-helical cytotoxic islet amyloid polypeptide oligomers which interact with cell membranes, following a complete internalization that leads to cellular apoptosis. Moreover, antibodies which bind the oligomers and neutralize the cytotoxicity were exclusively identified in the serum of type 2 diabetes patients. Here, we examined the usage of the newly characterized oligomers as an active immunization agent targeting amyloid self- assembly in a diabetes-associated phenotype transgenic mice model. Immunized transgenic mice showed an increase in hIAPP-antibody serum titer as well as improvement in diabetes-associated parameters. Lower fasting blood glucose levels, higher insulin, and lower islet amyloid polypeptide accumulation were observed. Furthermore, antibodies derived from the immunized mice reduced hIAPP oligomers cytotoxicity towards \u03b2-cells in a dose-dependent manner. This study highlights the significance of targeting the early amyloid self-assembly events for potential disease management. Furthermore, it demonstrates that \u03b1-helical oligomers conformers are valid epitope for the development of future immunization therapy.<\/jats:p>","DOI":"10.1038\/s41598-017-14311-1","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T10:17:55Z","timestamp":1508408275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Active Immunization Against hIAPP Oligomers Ameliorates the Diabetes- Associated Phenotype in a Transgenic Mice Model"],"prefix":"10.1038","volume":"7","author":[{"given":"Yaron","family":"Bram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivan","family":"Peled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayanti","family":"Brahmachari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Harlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Gazit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"key":"14311_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrm2327","volume":"9","author":"DM Muoio","year":"2008","unstructured":"Muoio, D. M. & Newgard, C. B. Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell Biol. \n                           9, 193\u2013205 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"14311_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler, A. E. et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes \n                           52, 102\u2013110 (2003).","journal-title":"Diabetes"},{"key":"14311_CR3","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1172\/JCI71981","volume":"124","author":"JF Rivera","year":"2014","unstructured":"Rivera, J. F., Costes, S., Gurlo, T., Glabe, C. G. & Butler, P. C. Autophagy defends pancreatic \u03b2 cells from Human islet amyloid polypeptide-induced toxicity. J. Clin. Invest. \n                           124, 3489\u20133500 (2014).","journal-title":"J. Clin. Invest."},{"key":"14311_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/physrev.00042.2009","volume":"91","author":"P Westermark","year":"2011","unstructured":"Westermark, P., Andersson, A. & Westermark, G. T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. \n                           91, 795\u2013826 (2011).","journal-title":"Physiol. Rev."},{"key":"14311_CR5","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s00018-011-0905-1","volume":"69","author":"TA Lutz","year":"2012","unstructured":"Lutz, T. A. Control of energy homeostasis by amylin. Cell. Mol. Life Sci. \n                           69, 1947\u201365 (2012).","journal-title":"Cell. Mol. Life Sci."},{"key":"14311_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1084\/jem.5.4.397","volume":"5","author":"EL Opie","year":"1901","unstructured":"Opie, E. L. On the Relation of Chronic Interstitial Pancreatitis to the Islands of Langerhans and to Diabetes Mellitus. J. Exp. Med. \n                           5, 397\u2013428 (1901).","journal-title":"J. Exp. Med."},{"key":"14311_CR7","first-page":"414","volume":"127","author":"P Westermark","year":"1987","unstructured":"Westermark, P., Wernstedt, C., O\u2019Brien, T. D., Hayden, D. W. & Johnson, K. H. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am. J. Pathol. \n                           127, 414\u20137 (1987).","journal-title":"Am. J. Pathol."},{"key":"14311_CR8","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","volume":"84","author":"GJ Cooper","year":"1987","unstructured":"Cooper, G. J. et al. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA \n                           84, 8628\u201332 (1987).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"14311_CR9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/368756a0","volume":"368","author":"A Lorenzo","year":"1994","unstructured":"Lorenzo, A., Razzaboni, B., Weir, G. C. & Yankner, B. A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature \n                           368, 756\u2013760 (1994).","journal-title":"Nature"},{"key":"14311_CR10","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","volume":"93","author":"J Janson","year":"1996","unstructured":"Janson, J. et al. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc. Natl. Acad. Sci. USA \n                           93, 7283\u20138 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"14311_CR11","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.2337\/diabetes.52.9.2304","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler, A. E., Janson, J., Soeller, W. C. & Butler, P. C. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes \n                           52, 2304\u201314 (2003).","journal-title":"Diabetes"},{"key":"14311_CR12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","volume":"155","author":"LF Lue","year":"1999","unstructured":"Lue, L. F. et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease. Am. J. Pathol. \n                           155, 853\u201362 (1999).","journal-title":"Am. J. Pathol."},{"key":"14311_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean, C. A. et al. Soluble pool of A\u03b2 amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann. Neurol. \n                           46, 860\u2013866 (1999).","journal-title":"Ann. Neurol."},{"key":"14311_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesn\u00e9","year":"2006","unstructured":"Lesn\u00e9, S. et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature \n                           440, 352\u2013357 (2006).","journal-title":"Nature"},{"key":"14311_CR15","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner, B. & Jappelli, R. In vivo demonstration that \u03b1-synuclein oligomers are toxic. Proc. Natl. Acad. Sci. \n                           108, 4194\u20134199 (2011).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"14311_CR16","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/brain\/awu057","volume":"137","author":"E Rockenstein","year":"2014","unstructured":"Rockenstein, E. et al. Accumulation of oligomer-prone \u03b1-synuclein exacerbates synaptic and neuronal degeneration in vivo. . Brain \n                           137, 1496\u2013513 (2014).","journal-title":". Brain"},{"key":"14311_CR17","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jmb.2010.10.025","volume":"404","author":"H Jang","year":"2010","unstructured":"Jang, H. et al. \u03b2-Barrel Topology of Alzheimer\u2019s \u03b2-Amyloid Ion Channels. J. Mol. Biol. \n                           404, 917\u2013934 (2010).","journal-title":"J. Mol. Biol."},{"key":"14311_CR18","doi-asserted-by":"publisher","first-page":"46363","DOI":"10.1074\/jbc.C400260200","volume":"279","author":"R Kayed","year":"2004","unstructured":"Kayed, R. et al. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem. \n                           279, 46363\u201346366 (2004).","journal-title":"J. Biol. Chem."},{"key":"14311_CR19","doi-asserted-by":"publisher","first-page":"10971","DOI":"10.1021\/bi034889i","volume":"42","author":"Y Porat","year":"2003","unstructured":"Porat, Y., Kolusheva, S., Jelinek, R. & Gazit, E. The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. Biochemistry \n                           42, 10971\u20137 (2003).","journal-title":"Biochemistry"},{"key":"14311_CR20","doi-asserted-by":"publisher","first-page":"10427","DOI":"10.1073\/pnas.0502066102","volume":"102","author":"A Quist","year":"2005","unstructured":"Quist, A. et al. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. USA \n                           102, 10427\u201332 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"14311_CR21","doi-asserted-by":"publisher","first-page":"31374","DOI":"10.1074\/jbc.M400348200","volume":"279","author":"M Bucciantini","year":"2004","unstructured":"Bucciantini, M. et al. Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J. Biol. Chem. \n                           279, 31374\u201382 (2004).","journal-title":"J. Biol. Chem."},{"key":"14311_CR22","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1016\/j.bpj.2014.09.047","volume":"107","author":"DE Schlamadinger","year":"2014","unstructured":"Schlamadinger, D. E. & Miranker, A. D. Fiber-Dependent and -Independent Toxicity of Islet Amyloid Polypeptide. Biophys. J. \n                           107, 2559\u20132566 (2014).","journal-title":"Biophys. J."},{"key":"14311_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep04267","volume":"4","author":"Y Bram","year":"2014","unstructured":"Bram, Y. et al. Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies. Sci. Rep. \n                           4, 4267 (2014).","journal-title":"Sci. Rep."},{"key":"14311_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2337\/db06-0734","volume":"56","author":"RA Ritzel","year":"2007","unstructured":"Ritzel, R. A., Meier, J. J., Lin, C. Y., Veldhuis, J. D. & Butler, P. C. Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets. Diabetes \n                           56, 65\u201371 (2007).","journal-title":"Diabetes"},{"key":"14311_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science \n                           300, 486\u20139 (2003).","journal-title":"Science"},{"key":"14311_CR26","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.2337\/db06-1579","volume":"56","author":"C-Y Lin","year":"2007","unstructured":"Lin, C.-Y. et al. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h- IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice. Diabetes \n                           56, 1324\u201332 (2007).","journal-title":"Diabetes"},{"key":"14311_CR27","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1126\/science.1213151","volume":"335","author":"A Laganowsky","year":"2012","unstructured":"Laganowsky, A. et al. Atomic view of a toxic amyloid small oligomer. Science \n                           335, 1228\u201331 (2012).","journal-title":"Science"},{"key":"14311_CR28","doi-asserted-by":"publisher","first-page":"9496","DOI":"10.1021\/bi060579z","volume":"45","author":"JD Knight","year":"2006","unstructured":"Knight, J. D., Hebda, J. A. & Miranker, A. D. Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide. Biochemistry \n                           45, 9496\u2013508 (2006).","journal-title":"Biochemistry"},{"key":"14311_CR29","doi-asserted-by":"publisher","first-page":"17205","DOI":"10.1074\/jbc.M801383200","volume":"283","author":"M Apostolidou","year":"2008","unstructured":"Apostolidou, M., Jayasinghe, S. A. & Langen, R. Structure of alpha-helical membrane- bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding. J. Biol. Chem. \n                           283, 17205\u201310 (2008).","journal-title":"J. Biol. Chem."},{"key":"14311_CR30","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1021\/ja710484d","volume":"130","author":"JR Brender","year":"2008","unstructured":"Brender, J. R. et al. Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide. J. Am. Chem. Soc. \n                           130, 6424\u20136429 (2008).","journal-title":"J. Am. Chem. Soc."},{"key":"14311_CR31","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1096\/fj.11-194613","volume":"26","author":"M Magzoub","year":"2012","unstructured":"Magzoub, M. & Miranker, A. D. Concentration-dependent transitions govern the subcellular localization of islet amyloid polypeptide. FASEB J. \n                           26, 1228\u201338 (2012).","journal-title":"FASEB J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14311-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14311-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14311-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T12:32:13Z","timestamp":1671798733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14311-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["14311"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-14311-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,25]]},"assertion":[{"value":"8 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14031"}}